Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citrus/Cydonia comp. 1% for grass pollen allergic rhinitis
2009-018112-26Phase 3Active
- Sponsor
- Weleda
- Start
- Feb 2010
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in seasonal allergic rhinitis (SAR) comparing Citrus/Cydonia comp. 1% injection with Placebo injection (2 arms). Primary endpoints: Days with symptom control and Safety and tolerability. Started Feb 2010; status: active.
02
Drugs
Citrus + Cydonia comp.
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on 2009-018112-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-018112-26.